Dextran is a versatile agent used in cancer therapies to enhance drug delivery systems, improving targeted delivery. It can also be utilised for cell separation and can enhance antibody-drug conjugates for precise treatment, making it a valuable tool in modern cancer therapies.
Dextrans are valuable in cancer therapies due to their versatility. They can form nanoparticles for targeted drug delivery, allowing cancer drugs to focus on tumor cells, enhancing efficacy and reducing side effects.
Additionally, dextran-coated nanoparticles are used in cell separation to isolate cancer stem cells, aiding in more precise treatments.
Dextrans are also utilised in antibody-drug conjugates (ADCs), linking antibodies to cancer drugs, which enables targeted treatment while minimizing damage to healthy tissues, thus improving therapeutic outcomes in cancer patients.
Contact us